The Company is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel small molecule therapeutics for oncology and other unmet medical needs.


Updates from The Motley Fool

Latest updates on Sunesis Pharmaceuticals from Fool.com.


Stock Performance

SNSS vs. S&P 500 | 2 Year Performance
View Interactive SNSS Charts
Sponsored by

Key Data Points

Primary metrics and data points about Sunesis Pharmaceuticals.
Current Price: $4.44
Prev Close: $4.52
Open: $4.51
Bid: $2.99
Ask: $4.53
Day's Range: $4.39 - $4.55
52wk Range: $2.63 - $6.96
Volume: 18,288
Avg Vol 167,918
Market Cap: $335.09M
P/E (ttm): -1.57
EPS (ttm): -$2.88
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Sunesis Pharmaceuticals.
CAPS Rating 2 out of 5
 
96 Outperform
21 Underperform
CAPS All Stars
 
29 Outperform
12 Underperform

How do you think Sunesis Pharmaceuticals will perform against the market?



You pick for Sunesis Pharmaceuticals is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Dan Swisher Jr., CEO

83% Approve

Based on 4 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Sunesis Pharmaceuticals.

The Company is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel small molecule therapeutics for oncology and other unmet medical needs.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers